Type I aortic dissection in a patient with human immunodeficiency virus infection

被引:3
作者
Shen, Yinzhong [1 ]
Song, Wei [1 ]
Lu, Hongzhou [1 ]
机构
[1] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 201508, Peoples R China
关键词
Aortic dissection; acquired immunodeficiency syndrome; CARDIOVASCULAR MANIFESTATIONS; ANTIRETROVIRAL THERAPY; HIV; MANAGEMENT; DISEASE; RISK; LOPINAVIR/RITONAVIR; COMPLICATIONS; ASSOCIATION; SURGERY;
D O I
10.5582/bst.2012.v6.3.143
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The use of highly active antiretroviral therapy in patients with HIV infection has significantly reduced HIV-related infectious complications and improved their survival. With effective antiretroviral therapy, cardiovascular disease has gained prominence as a cause of morbidity and mortality in HIV-infected persons. Aortic dissection is an uncommon but potentially fatal disease with catastrophic complications. The spread of AIDS is a major public health problem in China, but there is scant literature regarding the clinical outcome for HIV/AIDS patients with aortic dissection in China. This case report describes a patient with HIV and type I aortic dissection who survived without surgical repair. This report is provided to describe a detailed and successful outcome for a patient with type I aortic dissection and HIV in China.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 19 条
[1]   Repair type I aortic dissection in a patient with human immunodeficiency virus infection [J].
Baciewicz, FA ;
MacArthur, RD ;
Crane, LR .
ANNALS OF THORACIC SURGERY, 2003, 76 (03) :917-919
[2]   Cardiovascular manifestations of HIV infection [J].
Barbaro, G .
CIRCULATION, 2002, 106 (11) :1420-1425
[3]  
Blanco F, 2010, AIDS REV, V12, P231
[4]   The Relationship Between HIV Infection and Cardiovascular Disease [J].
Dau, Birgitt ;
Holodniy, Mark .
CURRENT CARDIOLOGY REVIEWS, 2008, 4 (03) :203-218
[5]   The AIDS epidemic - Considerations for the 21st century [J].
Fauci, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1046-1050
[6]   Acceleration of confirmed coronary artery disease among HIV-infected patients on potent antiretroviral therapy [J].
Friedl, AC ;
Jost, CHA ;
Schalcher, C ;
Amann, FW ;
Flepp, M ;
Jenni, R ;
Linka, A ;
Weber, R .
AIDS, 2000, 14 (17) :2790-2792
[7]   Cardiovascular disease risk factors in HIV patients -: association with antiretroviral therapy.: Results from the DAD study [J].
Friis-Moller, N ;
Weber, R ;
Reiss, P ;
Thiébaut, R ;
Kirk, O ;
Monforte, AD ;
Pradier, C ;
Morfeldt, L ;
Mateu, S ;
Law, M ;
El-Sadr, W ;
De Wit, S ;
Sabin, CA ;
Phillips, AN ;
Lundgren, JD .
AIDS, 2003, 17 (08) :1179-1193
[8]   Class of antiretroviral drugs and the risk of myocardial infarction [J].
Friis-Moller, Nina ;
Reiss, Peter ;
Sabin, Caroline A. ;
Weber, Rainer ;
Monforte, Antonella d'Arminio ;
El-Sadr, Wafaa ;
De Wit, Stephane ;
Kirk, Ole ;
Fontas, Eric ;
Law, Matthew G. ;
Phillips, Andrew ;
Lundgren, Jens D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (17) :1723-1735
[9]   Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America [J].
Gupta, SK ;
Eustace, JA ;
Winston, JA ;
Boydstun, II ;
Ahuja, TS ;
Rodriguez, RA ;
Tashima, KT ;
Roland, M ;
Franceschini, N ;
Palella, FJ ;
Lennox, JL ;
Klotman, PE ;
Nachman, SA ;
Hall, SD ;
Szczech, LA .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1559-1585
[10]   Cardiovascular manifestations in human immunodeficiency virus-infected patients [J].
Khunnawat, Chotikorn ;
Mukeji, Siddharth ;
Havlichek, Daniel, Jr. ;
Touma, Rabih ;
Abela, George S. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (05) :635-642